Chemoinformaics analysis of 2,3-Dimethylbenzoic acid
| Molecular Weight | 150.177 | nRot | 1 |
| Heavy Atom Molecular Weight | 140.097 | nRig | 7 |
| Exact Molecular Weight | 150.068 | nRing | 1 |
| Solubility: LogS | -2.485 | nHRing | 0 |
| Solubility: LogP | 2.82 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 23.3019 |
| nHD | 1 | BPOL | 10.9001 |
| QED | 0.664 |
| Synth | 1.49 |
| Natural Product Likeliness | -0.696 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.061 |
| HIA | 0.004 |
| CACO-2 | -4.646 |
| MDCK | 0.000024 |
| BBB | 0.27 |
| PPB | 0.803847 |
| VDSS | 0.33 |
| FU | 0.130312 |
| CYP1A2-inh | 0.186 |
| CYP1A2-sub | 0.741 |
| CYP2c19-inh | 0.056 |
| CYP2c19-sub | 0.066 |
| CYP2c9-inh | 0.072 |
| CYP2c9-sub | 0.214 |
| CYP2d6-inh | 0.028 |
| CYP2d6-sub | 0.129 |
| CYP3a4-inh | 0.029 |
| CYP3a4-sub | 0.149 |
| CL | 3.371 |
| T12 | 0.853 |
| hERG | 0.038 |
| Ames | 0.012 |
| ROA | 0.69 |
| SkinSen | 0.212 |
| Carcinogencity | 0.041 |
| EI | 0.996 |
| Respiratory | 0.046 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.848647 |